Attenuation of antipsychotic-induced hyperprolactinemia with clozapine

Journal of Child and Adolescent Psychopharmacology

Volumn 7, Issue 1, 1997, Pages 65-69

  Bunker, Mark T ^a   Marken, Patricia A ^a,b   Schneiderhan, Mark E ^a   Ruehter, Valerie L ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LITHIUM; ORAL CONTRACEPTIVE AGENT; PROPRANOLOL; THIORIDAZINE; VALPROATE SEMISODIUM;

ADOLESCENT; AMENORRHEA; ARTICLE; CASE REPORT; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; MENTAL DISEASE; PROLACTIN BLOOD LEVEL;

EID: 0030948752     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1997.7.65     Document Type: Article

References (15)

1. Baldessarini RJ: Drugs and the treatment of psychiatric disorders. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. Edited by Hardman JG, Limbird LE. New York, McGraw-Hill, 1996, pp 399-430
2. Beaumont P, Bruwer J, Pimstone B: Bromo-ergocryptine in the treatment of phenothiazine induced galactorrhea. Br J Psychiatry 126:285-288, 1975
3. Bitton R, Schneider B: Endocrine, metabolic and nutritional effects of psychotropic drugs. In: Adverse Effects of Psychotropic Drugs. Edited by Kane JM, Lieberman JA. New York, Guilford, 1992, pp 341-355
4. Correa N, Opler LA, Kay SR: Amantadine in the treatment of neuroendocrine side effects of neuroleptics. J Clin Psychopharmacol 137:1117-1118, 1981
5. Erhardt VR, Goldman MB: Adverse endocrine effects. In: Drug-Induced Dysfunction in Psychiatry. Edited by Kashavan MS, Kennedy JS. New York, Hemisphere Publishing Company, 1992, pp 293-310
6. Ghadirian A, Chouinard G, Annabel L: Sexual dysfunction and plasma prolactin levels in neuroleptic treated schizophrenic outpatients. J Nerv Ment Dis 170:463-467, 1982
7. Gudelsky GA, Nash JF, Koenig JI, Meltzer HY: Neuroendocrine effects of typical and atypical antipsychotics in rats. Psychopharmacol Bull 23:483-486, 1987
8. Inoue H, Hazama H, Ogura C: Neuroendocrinological study of amenorrhea induced by antipsychotic drugs [Letter]. Folia Psychiatr Neurol (Jpn) 34:181, 1980
9. Kane JM, Cooper TB, Sachar EJ, Halpern FS, Bailine S: Clozapine: Plasma levels and prolactin response. Psychopharmacology 73:184-187, 1981
10. Lieberman JA, Kane JM, Johns CA: Clozapine: Guidelines for clinical management. J Clin Psychiatry 50:329-338, 1989
11. McEvoy GK (ed): American Hospital Formulary Service Drug Information 1996. Bethesda, American Society of Health-System Pharmacists, 1996
12. Meltzer HY, Goode DJ, Schyve PM, Young M, Fang VS: Effect of clozapine on human serum prolactin levels. Am J Psychiatry 136:1550-1555, 1979
13. Moore KE, Lookingland KJ: Dopaminergic neuronal systems in the hypothalamus. In: Psychopharmacology: The Fourth Generation of Progress. Edited by Kupfer DJ, Bloom FE. New York, Raven Press, 1995, pp 245-256
14. Perry PJ, Alexander B, Liskow BI: Psychotropic Drug Handbook, Sixth Edition. Cincinnati, Harvey Whitney Books, 1991, p 22
15. Vance ML, Thorner MD: Prolactin: Hyperprolactinemic syndromes and management. In: Endocrinology, Third Edition. Edited by DeGroot LJ. Philadelphia, WB Saunders, 1995, pp 394-405